who-h il 2000-2011 · i a k wl g this technical paper was written by colin mathers and li liu with...
TRANSCRIPT
![Page 1: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/1.jpg)
WHO-CHERG methods and data
sources for child causes of death
2000-2011
Department of Health Statistics and Information Systems (WHO, Geneva)
and WHO-UNICEF Child Health Epidemiology Reference Group (CHERG)
June 2013
Global Health Estimates Technical Paper WHO/HIS/HSI/GHE/2013.2
![Page 2: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/2.jpg)
i
Acknowledgments
This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu
Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates of regional child deaths by cause for years
2000-2011 were primarily prepared by Li Liu, Bob Black, Simon Cousens and Joy Lawn, of the Child
Health Epidemiology Reference Group (CHERG), and Colin Mathers and Doris Ma Fat (from the Mortality
and Burden of Disease Unit in the WHO Department of Health Statistics and Information Systems), with
advice and inputs from other members of CHERG, WHO Departments, collaborating UN Agencies, and
other WHO expert advisory groups and academic collaborators.
The Child Health Epidemiology Reference Group has been supported by a grant from the Bill & Melinda
Gates Foundation to the US Fund for UNICEF for CHERG.
These estimates make considerable use of the all-cause mortality estimates developed by the
Interagency Group on Child Mortality Estimation (UN-IGME), and the births estimates of the UN
Population Division, as well as specific inputs for certain vaccine-preventable diseases developed under
the oversight of the WHO Quantitative Immunization and Vaccines Related Research (QUIVER) Advisory
Group. While it is not possible to name all those who provided advice, assistance or data, both inside
and outside WHO, we would particularly like to note the assistance and inputs provided by Diego
Bassani, Ties Boerma, Cynthia Boschi-Pinto, Tony Burton, Harry Campbell, Richard Cibulskis, Cristina
Garcia, Peter Ghys, Mie Inoue, Robert Jakob, Prabhat Jha, Hope Johnson, Mikkel Oestergaard, Igor
Rudan, Emily Simons, Karen Stanecki, Peter Strebel, Tessa Wardlaw, and Danzhen You.
Estimates and analysis are available at:
http://www.who.int/gho/mortality_burden_disease/en/index.html
For further information about the estimates and methods, please contact [email protected]
In this series
1. WHO methods and data sources for life tables 1990-2011 (Global Health Estimates Technical Paper
WHO/HIS/HSI/GHE/2013.1)
2. WHO-CHERG methods and data sources for child causes of death 2000-2011 (Global Health Estimates
Technical Paper WHO/HIS/HSI/GHE/2013.2)
3. WHO methods and data sources for global causes of death 2000-2011 (Global Health Estimates
Technical Paper WHO/HIS/HSI/GHE/2013.3)
![Page 3: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/3.jpg)
ii
Table of Contents
Acknowledgments .......................................................................................................................................... i
Table of Contents .......................................................................................................................................... ii
1 Introduction……………… ............................................................................................................................. 1
2 Population and all-cause mortality estimates for years 2000-2011 ........................................................ 1
2.1 Estimation of neonatal, infant and under-5 mortality rates............................................................ 1
2.2 Population and births estimates ...................................................................................................... 2
2.3 Mortality shocks – epidemics, conflicts and disasters ..................................................................... 2
3 Child mortality by cause .......................................................................................................................... 3
3.1 Causes of under 5 death in countries with good death registration data ....................................... 3
3.2 Causes of neonatal death (deaths at less than 28 days of age) ....................................................... 3
3.3 Causes of child death at ages 1-59 months –low mortality countries ............................................. 4
3.4 Causes of child death at ages 1-59 months –high mortality countries ........................................... 4
3.5 Causes of child death for China and India ....................................................................................... 5
4 Methods for cause-specific revisions and updates.................................................................................. 5
4.1 HIV/AIDS........................................................................................................................................... 5
4.2 Malaria ............................................................................................................................................. 5
4.3 Whooping cough .............................................................................................................................. 6
4.4 Measles ............................................................................................................................................ 6
4.5 Conflict and natural disasters .......................................................................................................... 7
5 Uncertainty of estimates ......................................................................................................................... 7
References………………………………………………………………………………………………………………………………………………8
Annex Table A Methods used for estimation of child causes of death, by country, 2000-2011 .............. 10
Annex Table B First-level categories for analysis of child causes of death ............................................... 15
Annex Table C Re-assignment of ICD-10 codes for certain neonatal deaths ........................................... 16
Annex Table D Country groupings used for regional tabulations ............................................................. 18
D.1 WHO Regions and Member States ................................................................................................ 18
D.2 Countries grouped by WHO Region and average income per capita* .......................................... 19
D.3 World Bank income grouping* ...................................................................................................... 20
D.4 World Bank Regions ....................................................................................................................... 21
D.5 Millennium Development Goal (MDG) Regions ............................................................................ 22
![Page 4: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/4.jpg)
World Health Organization Page 1
1 Introduction
Cause-specific estimates of deaths for children under age 5 were estimated for 17 cause categories for
years 2000-2010 using methods described elsewhere by Liu et al. (1) and on the WHO website (2). These
estimates were prepared by the WHO Department of Health Statistics and Information Systems and the
Child Health Epidemiology Reference Group (CHERG), with inputs and assistance from other WHO
Departments and UN Agencies. These previously published estimates for years 2000-2010 have been
updated at regional level by WHO and CHERG to take account of revisions in child mortality levels (3), as
well as cause-specific estimates for HIV, tuberculosis, measles and malaria deaths (as described in
Section 4). Inputs to the multivariate cause composition models were also updated as described below
in Section 3.
These estimates of child deaths by cause also form an input to the more general regional estimates of
deaths by cause, age and sex also released on the WHO website in June 2013 as a part of the WHO
Global Health Estimates (GHE) (4). Both the child causes of death and the Global Health Estimates will be
updated to years 2000-2012 later in 2013, and released at country level following consultation with
WHO Member States.
These estimates of child deaths by cause represent the best estimates of WHO and CHERG, based on the
evidence available to them up until May 2013, rather than representing the official estimates of
Member States, and have not necessarily been endorsed by Member States. They have been computed
using standard categories, definitions and methods to ensure cross-national comparability and may not
be the same as official national estimates produced using alternate, potentially equally rigorous
methods. The following sections of this document provide explanatory notes on data sources and
methods for preparing child mortality estimates by cause.
2 Population and all-cause mortality estimates for years 2000-2011
2.1 Estimation of neonatal, infant and under-5 mortality rates
Methods for estimating time series for neonatal, infant and under-5 mortality rates have been
developed and agreed upon within the Inter-agency Group for Child Mortality Estimation (UN-IGME)
which is made up of WHO, UNICEF, UN Population Division, World Bank and academic groups. UN-IGME
annually assesses and adjusts all available surveys, censuses and vital registration data, to then estimate
the country-specific trends in under-five mortality per 1000 live births (U5MR) over the past few
decades in order to predict the rates for the reference years (3). All data sources and estimates are
documented on the UN-IGME website.1 For countries with complete recording of child deaths in death
registration systems, these are used as the source of data for the estimation of trends in neonatal, infant
and child mortality. For countries with incomplete death registration, all other available census and
survey data sources, which meet quality criteria, are used. UN-IGME methods are documented in a
series of papers published in a collection in 2012 (5).
For data from civil registration, the neonatal mortality per 1000 live births (NMR) is calculated as the
number of neonatal death divided by the live births reported from the country when available. For
household surveys, child and neonatal mortality rates are calculated from the full birth history (FBH)
data, where women are asked for the date of birth of each of their children, whether the child is still
1 www.childmortality.org
![Page 5: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/5.jpg)
World Health Organization Page 2
alive, and if not the age at death FBH data, collected by all DHS surveys, allow the calculation of child
mortality indicators for specific time periods in the past; DHS publishes child mortality estimates for five
5-year periods before the survey, that is, 0 to 4, 5 to 9, 10 to 14 etc.
A database consisting of pairs of NMRs and U5MRs was compiled. For a given year, NMR and U5MR
were included in the database when data for both of these were available. To ensure consistency with
U5MR estimates produced by UN-IGME, U5MR and NMR data points were rescaled for all years to
match the UN-IGME estimates.
For countries where child mortality is strongly affected by HIV, the NMR was estimated initially using
neonatal and child mortality observations for non-AIDS deaths, calculated by subtracting from total
death rates the estimates HIV death rates in the neonatal and 1-59 month periods respectively, and
then AIDS neonatal deaths be added back on to the non-HIV neonatal deaths to compute the total
estimated neonatal death rate.
The following statistical model was used to estimate NMR:
log(NMR/1000) = α0+ β1*log(U5MR/1000) + β2*([log(U5MR/1000)] 2)
with additional random effect intercept parameters for both country and region. For countries with
good vital registration data covering the period 1990-2011, random effects parameters for slope or
trend parameters were also added. Based on predictive performance evaluation using ten-fold cross-
validation, the statistical model fitted to data point for 1990 onwards were retained and only the most
recent data point from each survey was included (6).
2.2 Population and births estimates
Total deaths by age and sex were estimated for each country by applying the UN-IGME estimates of
neonatal and under 5 mortality rates to the estimated total births and de facto resident population
estimates for children under age 5 prepared by the United Nations Population Division in its 2010
revision (7). They may thus differ slightly from official national estimates for corresponding years. Child
causes of death will be updated in their next revision to take account of revisions to population
estimates included in the World Population Prospects 2012 (released mid-June 2013) (8).
2.3 Mortality shocks – epidemics, conflicts and disasters
Country-specific estimates of deaths for organized conflicts and major natural disasters were prepared
for years 1990-2011 using data and methods documented in Section 4.5. For country-years where total
all-age death rates from these conflicts and disasters exceeded 1 per 10,000 population, neonatal and
child mortality rates were adjusted by adding the estimated age-specific components of the conflict and
disaster deaths.
As described in Section 4.4, deaths due to measles outbreaks and epidemics were identified and also
added to the smoothed all-cause envelopes estimated from the UN-IGME estimates for neonatal and
under 5 deaths.
![Page 6: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/6.jpg)
World Health Organization Page 3
3 Child mortality by cause
3.1 Causes of under 5 death in countries with good death registration data
Cause-of-death statistics are reported to WHO on an annual basis by country, year, cause, age and sex.
Most of these statistics can be accessed in the WHO Mortality Database (9). The number of countries
reporting data using the 10th revision of the International Classification of Diseases (ICD-10) (10) has
continued to increase. For these estimates, a total of 114 countries had data covering 80% or more of
deaths in the country, of which 93 countries were reporting data coded to the third or fourth character
of ICD-10 and 59 countries had data for years 2010 or 2011.
Death registration data were used directly for estimating causes of neonatal and under 5 child deaths
for countries with good quality vital registration (VR) data with population coverage of >80%. VR data
were considered as of good quality if the following criteria were met: (a) reasonable distribution of
deaths by cause were reported without excessive use of implausible codes or certain codes, and (b)
sufficient details of the coding was provided so that deaths could be grouped into appropriate
categories used in the analysis.
For countries with adequate death registration, data on causes of child deaths were extracted from the
WHO mortality database, adjusted for coverage incompleteness where needed, and grouped according
to the standard International Classification of Diseases, 10th revision (ICD-10). For earlier years when
ICD-9 codes were used, a mapping system was applied to convert them into ICD-10 codes (1,
webappendix). Certain neonatal codes were re-assigned from ill-defined codes to more plausible codes
(see Annex Table C). Annual data for years 2000 to the latest available year were included with data
closest to the estimating year used where possible. Where the latest year available was earlier than
2011, the cause distribution for the latest available year was assumed to apply for subsequent year(s),
which was then applied to the age-specific total number of child deaths.
3.2 Causes of neonatal death (deaths at less than 28 days of age)
The CHERG neonatal working group undertook an extensive exercise to derive mortality estimates for six
causes of neonatal death, including preterm birth, asphyxia, severe infection, diarrhoea, congenital
malformation and other causes (1). These cause categories are defined in Annex Table B.
Death registration data were used directly for 61 countries considered to have reliable information. For
another 51 low mortality countries, the cause distribution was estimated using a multinomial model
applied to death registration data. For 80 high mortality countries the cause distribution was estimated
using a multinomial model applied to (largely) verbal autopsy (VA) data from research studies (1). A total
of 90 studies in 34 countries in high mortality populations met the inclusion criteria. The multinomial
model for high mortality countries was generally used for countries with average U5MR>35 for the
period 2000-2010.
A separate cause category for neonatal pneumonia is included in the model, and the neonatal sepsis
category includes a number of neonatal infections, such as meningitis and tetanus, not separately
identified. The number of tetanus deaths was also modeled separately in a single cause model using
using a logistic regression model with percent of women who were literate, percent of births with skilled
attendant, and percent protected at birth by tetanus toxoid vaccine as covariates. The resulting cause-
specific inputs were adjusted country-by-country to fit the estimated neonatal death envelopes for
corresponding years.
Pending further revisions of the neonatal tetanus model to estimate longer-term trends in neonatal
tetanus deaths, estimates for 2011 and 2000 were based on projection and back-projection of the 2008
![Page 7: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/7.jpg)
World Health Organization Page 4
estimates using estimates of trends in tetanus deaths from the Institute for Health Metrics and
Evaluation (IHME) Global Burden of Disease (GBD) 2010 study (11).
3.3 Causes of child death at ages 1-59 months –low mortality countries
For 51 low mortality countries without VR data or with VR data not meeting quality criteria (see Section
3.1), the cause distribution was estimated using a multinomial model applied to death registration data.
This multinomial model applied to death registration data was generally used for countries with average
U5MR<35 for the period 2000-2010.
For the estimates for years 2000-2011, the previous vital registration-based multicause model (VRMCM)
was revised to include additional death registration data and to update time series for covariates and
extend them to 2011. The choice of covariates included in the model was not revisited for this regional-
level update. The multinomial logistic regression model was estimated using death registration data
from countries with >80% complete cause of death (CoD) certification for years 1990-2011 to estimate
the proportion of deaths due to pneumonia, diarrhea, meningitis, injuries, perinatal, congenital
anomalies, other non-communicable diseases (NCDs) and other causes.
The current version of the model used death registration data for the years 1990 to 2011, including
1,123 data points, representing 63 countries. The model included the following covariates that were
determined a priori: U5MR, GNI per capita (PPP, $international), WHO European and American regions.
Adjustments for the scaling-up of Hib vaccine occurred within the model. The proportional distribution
of causes of death was then applied to the HIV-free and measles-free envelope for children 1-59 months
of age. Jack-knife and Monte Carlo simulation methods were used to estimate uncertainty.
3.4 Causes of child death at ages 1-59 months –high mortality countries
For 79 high mortality countries (average U5MR>35 for the period 2000-2010), the cause distribution was
estimated using a multinomial model applied to (largely) verbal autopsy (VA) data from research studies
(1, 12, 13). The verbal autopsy-based multicause model (VAMCM) for deaths at ages 1-59 months was
used to derive mortality estimates for seven causes of postneonatal death, including pneumonia,
diarrhea, malaria, meningitis, injuries, congenital malformations, causes arising in the perinatal period
(prematurity, birth asphyxia and trauma, sepsis and other conditions of the newborn), and other causes,
based on 113 data points from 74 studies of postneonatal deaths from 33 countries that met inclusion
criteria2. Studies were predominantly from lower income high mortality countries. Malnutrition deaths
were included in the other cause of death category. Deaths due to unknown causes were excluded from
the analysis. Deaths due to measles and HIV/AIDS were estimated separately.
The resulting cause-specific inputs were adjusted country-by-country to fit the estimated 1-59 month
death envelopes (excluding HIV and measles deaths) for corresponding years and then estimates were
further adjusted for intervention coverage (pneumonia and meningitis estimates adjusted for use of Hib
vaccine; malaria estimates adjusted for insecticide treated mosquito nets (ITNs)). This method was used
for countries without useable death registration data and with U5MR>26 and gross national income per
capita less than $7,510.
2 Studies conducted in year 1980 or later, a multiple of 12 months in study duration, cause of death available for
more than a single cause, with at least 25 deaths in children <5 years of age, each death represented once, and less
than 25% of deaths due to unknown causes were included. Studies conducted in sub-groups of the study population
(e.g. intervention groups in clinical trials) and verbal autopsy studies conducted without use of a standardized
questionnaire or the methods could not be confirmed were excluded from the analysis.
![Page 8: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/8.jpg)
World Health Organization Page 5
3.5 Causes of child death for China and India
In order to estimate trends in under 5 causes of death for India, the previously developed subnational
analyses were further refined and used to develop national estimates for years 2000-2011 (14). For
neonates, a verbal autopsy multi-cause model (VAMCM) based on 37 sub-national Indian community-
based VA studies was used to predict the cause distribution of deaths at state level. The resulting cause-
specific proportions were applied to the estimated total number of neonatal deaths to obtain the
estimated number of deaths by cause at state level prior to summing to obtain national estimates.
For children who died in the ages of 1-59 months in India, the previously developed VAMCM was rerun
for years 2000-2011 using a total of 23 sub-national community-based VA studies plus 22 sets of
observations for the Indian states derived from the Million Death Study (15). Nine cause categories were
specified, including measles plus the eight specified in the post-neonatal VAMCM for other countries.
State-level measles deaths were then normalized to fit the national measles estimates produced by the
WHO IVB. State-level AIDS and malaria estimates were provided by UNAIDS and WHO malaria program,
respectively. All cause fractions were adjusted to sum to one. The state-level estimates were collapsed
to obtain national estimates at the end.
For China, updated IGME U5MR estimates in 2000-2011 were applied to the VA-based national cause-
specific models developed by Rudan and colleagues (16) to derive cause-fractions annually in this
period. Together with cause-specific inputs from WHO technical programmes and UNAIDS for measles,
meningitis, malaria and AIDS, the resulting cause-specific inputs for China were adjusted to fit the
estimated total deaths at ages 0-1 month and 1-59 months, respectively.
4 Methods for cause-specific revisions and updates
4.1 HIV/AIDS
For countries with death registration data, HIV/AIDS mortality estimates were generally based on the
most recently available vital registration data except where there was evidence of miscoding of
HIV/AIDS deaths. In such cases, a time series analysis of causes where there was likely miscoding of
HIV/AIDS deaths was carried out to identify and re-assign miscoded HIV/AIDS deaths. For other
countries, estimates were based on UNAIDS estimated HIV/AIDS mortality (17). It was assumed based
on advice from UNAIDS that 1% of HIV deaths under age 5 occurred in the neonatal period.
4.2 Malaria
Countries outside the WHO African Region and low transmission countries in Africa3.
Estimates of the number of cases were made by adjusting the number of reported malaria cases for
completeness of reporting, the likelihood that cases are parasite-positive and the extent of health
service use. The procedure, which is described in the World Malaria Report 2012 (18), combines data
reported by National Malaria Control Programs (reported cases, reporting completeness, likelihood that
cases are parasite positive) with those obtained from nationally representative household surveys on
health service use. If data from more than one household survey was available for a country, estimates
of health service use for intervening years were imputed by linear regression. If only one household
3 Botswana, Cape Verde, Eritrea, Madagascar, Namibia, Swaziland, South Africa, and Zimbabwe
![Page 9: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/9.jpg)
World Health Organization Page 6
survey was available then health service use was assumed to remain constant over time; analysis
summarized in the World Malaria Report 2008 (19) indicated that the percentage of fever cases seeking
treatment in public sector facilities varies little over time in countries with multiple surveys. Such a
procedure results in an estimate with wide uncertainty intervals around the point estimate.
The number of deaths was estimated by multiplying the estimated number of P. falciparum malaria
cases by a fixed case fatality rate for each country as described in the World Malaria Report 2012 (18).
This method is used for all countries outside the African Region and for countries within the African
Region where estimates of case incidence were derived from routine reporting systems and where
malaria causes less than 5% of all deaths in children under 5. A case fatality rate of 0·45% is applied to
the estimated number of P. falciparum cases for countries in the African Region and a case fatality rate
of 0·3% for P. falciparum cases in other Regions. In situations where the fraction of all deaths due to
malaria is small, the use of a case fatality rate in conjunction with estimates of case incidence was
considered to provide a better guide to the levels of malaria mortality than attempts to estimate the
fraction of deaths due to malaria.
Somalia, Sudan and high transmission countries in the WHO African Region.
Child malaria deaths were estimated using the VAMCM described in Section 3.4. The VAMCM derives
mortality estimates for malaria, as well as 7 other causes (pneumonia, diarrhea, congenital
malformation, causes arising in the perinatal period, injury, meningitis, and other causes) using
multinomial logistic regression methods to ensure that all 8 causes are estimated simultaneously with
the total cause fraction summing to 1. Malaria deaths were retrospectively adjusted for coverage of ITNs
and use of Haemophilus influenzae type b vaccine (1).
4.3 Whooping cough
An updated model of whooping cough (pertussis) mortality is being developed by the WHO Department
of Immunization, Vaccines and Biologicals (IVB). This model has not been finalized in time for the release
of these regional-level estimates but will be used to update the GHE estimates at country level later in
2013. In the interim, whooping cough mortality estimates from the IHME GBD 2010 (11) have been used
as an input to the WHO-CHERG analysis of child causes of death under age five (see Section 3.2).
4.4 Measles
To estimate deaths attributable to measles, a new model of measles mortality developed by WHO
Department of Immunization, Vaccines and Biologicals (IVB) was used to first estimate country-and-
year-specific cases using surveillance data (20). The improved statistical model firstly estimates measles
cases by country and year using surveillance data and making explicit projections about dynamic
transitions over time as well as overall patterns in incidence.
The age distribution of measles cases are then estimated using a logistic regression function fitted to
172,191 measles cases with data on age at infection from 102 countries over 2005-2009 extracted from
WHO's monthly measles case-based reporting system. Two explanatory variables were included in the
regression: 1) the 5 year rolling average of estimated MCV1 coverage, categorized in <60%, 60-84%, and
85-100%; and 2) geographic region classified in to 7 groups.
Country-specific measles case-fatality ratios (CFRs) for children 1-4 years of age were taken from a
comprehensive review of community-based studies (21). This review included 102 field studies
conducted in 29 countries during the period 1974-2007. The set of CFRs were revised for two countries
(India and Nepal) where additional studies have been published subsequent to the review (22, 23). The
![Page 10: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/10.jpg)
World Health Organization Page 7
same CFRs were used for infants and for children aged 1-4 years. For the period 2000-2011, we assumed
that age-specific CFRs are not declining over time.
Age-specific deaths are aggregated to derive measles deaths for all children below five and for ages five
and over. The new method takes into account herd immunity and produces results that are fairly
consistent with previous ones (24). Uncertainty is estimated by bootstrap sampling from the
distribution of incidence and age distribution estimates. Updated estimates of measles deaths by age
and country for years 2000-2011 were prepared using the above methods at the end of 2012 and
summary results published in the Weekly Epidemiological Record (25).These were used for this update
of GHE causes of death for years 2000-2011.
For countries experiencing measles outbreaks, the measles deaths were split into outbreak and endemic
deaths, the latter of which were smoothed using local regression (26). For the ages of 1-59 months, the
endemic measles deaths and AIDS deaths were added to the measles- and AIDS-free all-cause deaths for
which the VAMCM derived cause fractions were applied. The measles outbreak deaths were added back
at the end. In places where the outbreak deaths resulted in an increase in the all-cause deaths by 10% or
more, the original survey data were screened to examine whether a real increase in child mortality was
indicated for the outbreak year. If there were survey data available for the years around the outbreak
but no evidence of an increased mortality, the measles outbreak deaths were truncated at 10% of the
all-cause deaths. This was only necessary in few countries, almost all of which are in Africa and all
occurred in the early 2000s when more measles deaths were estimated.
4.5 Conflict and natural disasters
Country-specific estimates of war and conflict deaths were updated using information on conflict
intensity, time trends, and mortality obtained from a variety of published and unpublished war mortality
databases (27, section 3.4). Estimated deaths for major natural disasters were obtained from the
OFDA/CRED International Disaster Database (28). For the few countries where estimated all-age deaths
due to conflict and disasters exceeded 1 per 10,000 population, the estimated under 5 deaths were
added to the estimated deaths for injuries and all causes.
5 Uncertainty of estimates
Previously published country-level estimates for child causes of death 2000-2010 include 95%
uncertainty ranges. These were calculated from the uncertainty ranges for the estimated neonatal
deaths and deaths in the 1-59 month period, assuming zero correlation across the age groups.
For each of the multicause models for neonatal and 1-59 month deaths, a bootstrap approach was used.
One thousand bootstrap samples were drawn from the input data sets and the parameters of the
multinomial model re-estimated using the bootstrap sample. The re-estimated model was then used to
predict the country-specific cause distributions. The uncertainty ranges presented represent the 2.5th
and 97.5th centiles from the 1000 bootstrap samples.
For the next update of child causes of death at country level for years 2000-2012, cause-specific
uncertainty ranges will be revised. For the regional results released in June 2013, provisional country-
level estimates are aggregated to regional groupings. Uncertainty ranges for specific priority causes are
available in relevant cited publications.
![Page 11: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/11.jpg)
World Health Organization Page 8
References
(1) Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M,
Mathers C, Black RE, for the Child Health Epidemiology Reference Group of WHO and UNICEF.
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010
with time trends since 2000. Lancet, 2012, 379:2151-61.
(2) World Health Organization. Methodology for WHO mortality estimates. Available at:
http://www.who.int/healthinfo/statistics/mortality/en/index2.html
(3) UNICEF, WHO, The World Bank and UN Population Division. Levels and Trends of Child Mortality -
Report 2012, Estimates developed by the UN Inter-agency Group for Child Mortality Estimation.
New York, UNICEF, 2012.
(4) WHO estimates of global causes of death 2000-2011. Available at:
http://www.who.int/healthinfo/global_burden_disease/en/
(5) The PLoS Medicine Collection on Child Mortality Estimation Methods. PLoS Medicine, 2012.
Available at:
http://www.ploscollections.org/article/browseIssue.action?issue=info:doi/10.1371/issue.pcol.v07
.i19.
(6) Oestergaard MZ, et al. Neonatal Mortality Levels for 193 Countries in 2009 with Trends since 1990:
A Systematic Analysis of Progress, Projections, and Priorities. PLoS Medicine, 2011, 8(8):
e1001080. doi:10.1371/journal.pmed.1001080
(7) United Nations, Department of Economic and Social Affairs, Population Division. World Population
Prospects - the 2010 revision. New York, United Nations, 2011.
(8) United Nations, Department of Economic and Social Affairs, Population Division. World Population
Prospects - the 2012 revision. New York, United Nations, 2013.
(9) World Health Organization. Mortality Database. Available at:
http://www.who.int/healthinfo/mortality_data/en/index.html
(10) International Statistical Classification of Diseases and Related Health Problems – 10th Revision.
Geneva, World Health Organization, 1990.
(11) Lozano et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990
and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012,
380(9859):2095-128.
(12) Black RE, Cousens S, Johnson H et al. Global, Regional and National Causes of Child Mortality,
2008. Lancet, 2010, 375(9730):1969-87.
(13) Johnson H, Liu L, Walker CF, Black RE. Estimating the distribution of causes of child deaths in high
mortality countries with incomplete death certification. Int J Epidemiol, 2010, 39(4):1103-1114.
(14) Liu et al. National, regional and state-level causes of child mortality in India in 2000-2010: a
systematic sub-national analysis. Under preparation, 2013.
(15) Bassani DG, Kumar R, Awasthi S et al. Causes of neonatal and child mortality in India: a nationally
representative mortality survey. Lancet, 2010, 376(9755):1853-1860.
(16). Rudan I, Chan KY, Zhang JS et al. Causes of deaths in children younger than 5 years in China in
2008. Lancet, 2010, 375(9720):1083-1089.
(17) UNAIDS. 2012 UNAIDS Report on the Global AIDS Epidemic. Geneva, UNAIDS, 2012.
![Page 12: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/12.jpg)
World Health Organization Page 9
(18) World Health Organization. World Malaria Report 2012. Geneva, WHO, 2012.
(19) World Health Organization. World Malaria Report 2008. Geneva, WHO, 2008.
(20) Chen S, Fricks J, Ferrari MJ. Tracking measles infection through non-linear state space models.
Journal of the Royal Statistical Society Series C, 2011, 61 (1).
(21) Wolfson LJ, Grais RF, Luquero FJ, Birmingham ME, Strebel PM. Estimates of measles case fatality
ratios: a comprehensive review of community-based studies. Int J Epidemiol, 2009, 38(1):192-205.
(22) Joshi AB, Luman ET, Nandy R, Subedi BK, Liyanage JBL, Wierzba TF. Measles deaths in Nepal:
estimating the national case–fatality ratio. Bulletin of the World Health Organization, 2009,
87(6):456–465.
(23) Sudfeld CR, Halsey NA. Measles case fatality ratio in India a review of community based studies.
Indian Pediatr, 2009, 46(11):983-9.
(24) Wolfson LJ, Strebel PM, Gacic-Dobo M, Hoekstra EJ, McFarland JW, Hersh BS. Has the 2005
measles mortality reduction goal been achieved? A natural history modelling study. Lancet, 2007,
369(9557):191-200.
(25) World Health Organization. Progress in global control and regional elimination of measles, 2000-
2011. Weekly epidemiological record, 2013, 88(3):29-36.
(26) Cleveland WS, Loader CL. Smoothing by local regression: principles and methods. In: Haerdle W,
Schimek MG, editors. Statistical theory and computational aspects of smoothing. New York,
Springer, 1996, 10-49.
(27) World Health Organization. WHO methods and data sources for life tables 1990-2011 . Global
Health Estimates Technical Paper. Geneva, World Health Organization, 2013
(WHO/HIS/HSI/GHE/2013.1).
(28) CRED. EM-DAT: The CRED International Disaster Database. Belgium, Université Catholique de
Louvain, 2012. Available at: http://www.emdat.be/database
![Page 13: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/13.jpg)
World Health Organization Page 10
Annex Table A Methods used for estimation of child causes of death, by
country, 2000-2011
Country Method
Afghanistan VA (high mortality) multicause models
Albania VR multicause models
Algeria VA (high mortality) multicause models
Andorra VR multicause models
Angola VA (high mortality) multicause models
Antigua and Barbuda VR data (WHO tabulations)
Argentina VR data (WHO tabulations)
Armenia VR multicause models
Australia VR data (WHO tabulations)
Austria VR data (WHO tabulations)
Azerbaijan VA (high mortality) multicause models
Bahamas VR data (WHO tabulations)
Bahrain VR data (WHO tabulations)
Bangladesh VA (high mortality) multicause models
Barbados VR data (WHO tabulations)
Belarus VR multicause models
Belgium VR data (WHO tabulations)
Belize VR data (WHO tabulations)
Benin VA (high mortality) multicause models
Bhutan VA (high mortality) multicause models
Bolivia VA (high mortality) multicause models
Bosnia and Herzegovina VR multicause models
Botswana VA (high mortality) multicause models
Brazil VR data (WHO tabulations)
Brunei Darussalam VR multicause models
Bulgaria VR data (WHO tabulations)
Burkina Faso VA (high mortality) multicause models
Burundi VA (high mortality) multicause models
Cambodia VA (high mortality) multicause models
Cameroon VA (high mortality) multicause models
Canada VR multicause models plus VR data for 0-4 years
Cape Verde VR multicause models
Central African Republic VA (high mortality) multicause models
Chad VA (high mortality) multicause models
Chile VR data (WHO tabulations)
China National VA model based on subnational Chinese studies only
Colombia VR data (WHO tabulations)
![Page 14: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/14.jpg)
World Health Organization Page 11
Comoros VA (high mortality) multicause models
Congo VA (high mortality) multicause models
Cook Islands VR multicause models
Costa Rica VR data (WHO tabulations)
Cote d'Ivoire VA (high mortality) multicause models
Croatia VR data (WHO tabulations)
Cuba VR data (WHO tabulations)
Cyprus VR multicause models
Czech Republic VR data (WHO tabulations)
Democratic People's Republic of Korea VA (high mortality) multicause models
Democratic Republic of the Congo VA (high mortality) multicause models
Denmark VR data (WHO tabulations)
Djibouti VA (high mortality) multicause models
Dominica VR data (WHO tabulations)
Dominican Republic VA (high mortality) multicause models
Ecuador VR multicause models
Egypt VR multicause models
El Salvador VR multicause models
Equatorial Guinea VA (high mortality) multicause models
Eritrea VA (high mortality) multicause models
Estonia VR data (WHO tabulations)
Ethiopia VA (high mortality) multicause models
Fiji VR multicause models
Finland VR data (WHO tabulations)
France VR data (WHO tabulations)
Gabon VA (high mortality) multicause models
Gambia VA (high mortality) multicause models
Georgia VR multicause models
Germany VR data (WHO tabulations)
Ghana VA (high mortality) multicause models
Greece VR data (WHO tabulations)
Grenada VR data (WHO tabulations)
Guatemala VA (high mortality) multicause models
Guinea VA (high mortality) multicause models
Guinea-Bissau VA (high mortality) multicause models
Guyana VR data (WHO tabulations)
Haiti VA (high mortality) multicause models
Honduras VR multicause models
Hungary VR data (WHO tabulations)
Iceland VR data (WHO tabulations)
India State-level Indian-specific VA model
Indonesia VA (high mortality) multicause models
![Page 15: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/15.jpg)
World Health Organization Page 12
Iran (Islamic Republic of) VA (high mortality) multicause models
Iraq VA (high mortality) multicause models
Ireland VR data (WHO tabulations)
Israel VR data (WHO tabulations)
Italy VR data (WHO tabulations)
Jamaica VR multicause models
Japan VR data (WHO tabulations)
Jordan VR multicause models
Kazakhstan VA (high mortality) multicause models
Kenya VA (high mortality) multicause models
Kiribati VA (high mortality) multicause models
Kuwait VR multicause models plus VR data for 0-4 years
Kyrgyzstan VA (high mortality) multicause models
Lao People's Democratic Republic VA (high mortality) multicause models
Latvia VR data (WHO tabulations)
Lebanon VR multicause models
Lesotho VA (high mortality) multicause models
Liberia VA (high mortality) multicause models
Libyan Arab Jamahiriya VR multicause models
Lithuania VR data (WHO tabulations)
Luxembourg VR data (WHO tabulations)
Madagascar VA (high mortality) multicause models
Malawi VA (high mortality) multicause models
Malaysia VR multicause models
Maldives VR multicause models
Mali VA (high mortality) multicause models
Malta VR data (WHO tabulations)
Marshall Islands VA (high mortality) multicause models
Mauritania VA (high mortality) multicause models
Mauritius VR data (WHO tabulations)
Mexico VR data (WHO tabulations)
Micronesia (Federated States of) VA (high mortality) multicause models
Monaco VR multicause models
Mongolia VA (high mortality) multicause models
Montenegro VR data (WHO tabulations)
Morocco VA (high mortality) multicause models
Mozambique VA (high mortality) multicause models
Myanmar VA (high mortality) multicause models
Namibia VA (high mortality) multicause models
Nauru VA (high mortality) multicause models
Nepal VA (high mortality) multicause models
Netherlands VR data (WHO tabulations)
![Page 16: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/16.jpg)
World Health Organization Page 13
New Zealand VR data (WHO tabulations)
Nicaragua VR multicause models
Niger VA (high mortality) multicause models
Nigeria VA (high mortality) multicause models
Niue VR multicause models
Norway VR data (WHO tabulations)
Oman VR multicause models
Pakistan VA (high mortality) multicause models
Palau VR multicause models
Panama VR data (WHO tabulations)
Papua New Guinea VA (high mortality) multicause models
Paraguay VR multicause models
Peru VR multicause models
Philippines VA (high mortality) multicause models
Poland VR data (WHO tabulations)
Portugal VR multicause models plus VR data for 0-4 years
Qatar VR multicause models
Republic of Korea VR multicause models plus VR data for 0-4 years
Republic of Moldova VR data (WHO tabulations)
Romania VR data (WHO tabulations)
Russian Federation VR multicause models
Rwanda VA (high mortality) multicause models
Saint Kitts and Nevis VR data (WHO tabulations)
Saint Lucia VR multicause models plus VR data for 0-4 years
Saint Vincent and the Grenadines VR data (WHO tabulations)
Samoa VR multicause models
San Marino VR multicause models plus VR data for 0-4 years
Sao Tome and Principe VA (high mortality) multicause models
Saudi Arabia VR multicause models
Senegal VA (high mortality) multicause models
Serbia VR data (WHO tabulations)
Seychelles VR multicause models
Sierra Leone VA (high mortality) multicause models
Singapore VR data (WHO tabulations)
Slovakia VR data (WHO tabulations)
Slovenia VR data (WHO tabulations)
Solomon Islands VA (high mortality) multicause models
Somalia VA (high mortality) multicause models
South Africa VA (high mortality) multicause models
Spain VR data (WHO tabulations)
Sri Lanka VR multicause models
Sudan VA (high mortality) multicause models
![Page 17: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/17.jpg)
World Health Organization Page 14
Suriname VR data (WHO tabulations)
Swaziland VA (high mortality) multicause models
Sweden VR data (WHO tabulations)
Switzerland VR data (WHO tabulations)
Syrian Arab Republic VR multicause models
Tajikistan VA (high mortality) multicause models
Thailand VR multicause models
The former Yugoslav Republic of Macedonia VR multicause models plus VR data for 0-4 years
Timor-Leste VA (high mortality) multicause models
Togo VA (high mortality) multicause models
Tonga VR multicause models
Trinidad and Tobago VR data (WHO tabulations)
Tunisia VR multicause models
Turkey VR multicause models
Turkmenistan VA (high mortality) multicause models
Tuvalu VR multicause models
Uganda VA (high mortality) multicause models
Ukraine VR multicause models
United Arab Emirates VR multicause models
United Kingdom VR data (WHO tabulations)
United Republic of Tanzania VA (high mortality) multicause models
United States VR data (WHO tabulations)
Uruguay VR data (WHO tabulations)
Uzbekistan VA (high mortality) multicause models
Vanuatu VR multicause models
Venezuela VR data (WHO tabulations)
Viet Nam VR multicause models
Yemen VA (high mortality) multicause models
Zambia VA (high mortality) multicause models
Zimbabwe VA (high mortality) multicause models
![Page 18: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/18.jpg)
World Health Organization Page 15
Annex Table B First-level categories for analysis of child causes of
death
Cause name ICD-10 code
All causes A00-Y89
I. Communicable, maternal,
perinatal and nutritional
conditionsa
A00-B99, D50-D53, D64.9, E00-E02, E40-E64, G00, G03-G04, H65-H66, J00-J22, J85, N30, N34, N390, N70-N73, O00-P96, U04
HIV/AIDS B20-B24
Diarrhoeal diseases A00-A09
Pertussis A37
Tetanus A33-A35
Measles B05
Meningitis/encephalitis A39, A83-A87, G00, G03, G04
Malaria B50-B54, P37.3, P37.4
Acute respiratory infections H65-H66, J00-J22, J85, P23
Prematurity P01.0, P01.1, P07, P22, P25-P28, P61.2, P77
Birth asphyxia & birth trauma P01.7-P02.1, P02.4-P02.6, P03, P10-P15, P20-P21, P24, P50, P90-P91
Sepsis and other infectious conditions of the newborn
P35-P39 (exclude P37.3, P37.4)
Other Group I Remainder
II. Noncommunicable diseasesa C00-C97, D00-D48, D55-D64 (exclude D64.9), D65-D89, E03-E34, E65-E88, F01-
F99, G06-G98, H00-H61, H68-H93, I00-I99, J30-J84, J86-J98, K00-K92, L00-L98, M00-M99, N00-N28, N31-N32, N35-N64 (exclude N39.0), N75-N98, Q00-Q99
Congenital anomalies Q00-Q99
Other Group II Remainder
III. Injuries V01-Y89
a Deaths coded to “Symptoms, signs and ill-defined conditions” (780-799 in ICD-9 and R00-R99 in ICD-10) are distributed
proportionately to all causes within Group I and Group II.
![Page 19: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/19.jpg)
World Health Organization Page 16
Annex Table C Re-assignment of ICD-10 codes for certain neonatal
deaths
Cause Recode Cause Recode Cause Recode Cause Recode Cause Recode
A153 P370 D649 P614 I471 P291 J698 P249 K760 P788
A162 P370 D65 P60 I472 P291 J70 P24 K761 P788
A165 P370 D696 D694 I479 P291 J709 P249 K762 P788
A169 P370 D699 P549 I48 P29 J80 P22 K763 P788
A170 P370 E101 P702 I490 P291 J840 P258 K767 P788
A180 P370 E102 P702 I494 P291 J841 P258 K768 P788
A320 P372 E110 P702 I498 P291 J848 P258 K769 P788
A321 P372 E112 P702 I499 P291 J849 P258 K819 P788
A327 P372 E116 P702 I50 P29 J85 P28 K82 P78
A328 P372 E117 P702 I500 P290 J850 P288 K828 P788
A329 P372 E140 P702 I501 P290 J851 P288 K830 P788
A35 A33 E144 P702 I509 P290 J852 P288 K831 P788
A40 P36 E145 P702 I517 Q248 J860 P288 K838 P788
A401 P360 E147 P702 I518 Q248 J869 P288 K839 P788
A402 P361 E149 P702 I519 Q249 J90 P28 K85 P78
A403 P361 E343 P051 I60 P52 J930 P251 K868 P788
A408 P361 E86 P74 I603 P525 J931 P251 K869 P788
A409 P361 E87 P74 I607 P525 J938 P251 K904 P788
A41 P36 E870 P742 I608 P525 J939 P251 K909 P788
A410 P362 E871 P742 I609 P525 J940 P288 K920 P540
A412 P363 E872 P740 I61 P52 J941 P288 K922 P543
A413 P368 E874 P748 I610 P524 J942 P548 K928 P788
A415 P368 E875 P743 I612 P524 J948 P288 K929 P789
A418 P368 E876 P743 I615 P524 J96 P28 N133 Q620
A419 P369 E877 P744 I616 P524 J960 P285 N139 Q623
B00 P35 E878 P744 I618 P524 J961 P285 N17 P96
B000 P352 F322 P914 I619 P524 J969 P285 N170 P960
B004 P352 F328 P914 I620 P528 J980 P288 N171 P960
B007 P352 F329 P914 I629 P529 J981 P281 N172 P960
B008 P352 F439 P209 I632 P529 J982 P250 N179 P960
B009 P352 G91 Q03 I633 P529 J984 P288 N180 P960
B01 P35 G911 Q039 I634 P529 J985 P288 N188 P960
B010 P358 G912 Q039 I635 P529 J986 P288 N189 P960
B011 P358 G913 Q039 I638 P529 J988 P288 N19 P96
B012 P358 G919 Q039 I639 P529 J989 P289 N359 Q643
B018 P358 G930 Q046 I64 P52 K220 Q395 N390 P393
B019 P358 G931 P219 I671 I607 K311 Q400 N433 P835
B059 P358 G936 P524 J12 P23 K44 Q79 N883 P010
B060 P350 G952 P025 J120 P230 K440 Q790 R001 P209
B068 P350 I050 Q232 J121 P230 K441 Q790 R011 P298
![Page 20: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/20.jpg)
World Health Organization Page 17
Cause Recode Cause Recode Cause Recode Cause Recode Cause Recode
B069 P350 I059 Q238 J128 P230 K449 Q790 R030 P292
B09 P35 I071 Q228 J129 P230 K561 Q438 R040 P548
B25 P35 I080 Q238 J13 P23 K562 Q438 R042 P269
B250 P351 I340 Q233 J14 P23 K565 Q433 R048 P548
B251 P351 I348 Q238 J15 P23 K566 P769 R049 P548
B258 P351 I35 Q23 J150 P236 K57 Q43 R05 P28
B259 P351 I350 Q230 J151 P235 K593 Q431 R060 P228
B270 P358 I351 Q231 J152 P232 K625 P542 R064 P228
B370 P375 I352 Q238 J153 P233 K631 P780 R068 P228
B371 P375 I359 Q238 J154 P236 K633 P788 R090 P219
B372 P375 I370 Q221 J155 P234 K65 P78 R092 P285
B373 P375 I379 Q223 J156 P236 K650 P781 R160 Q447
B374 P375 I38 I42 J157 P236 K659 P781 R162 Q447
B375 P375 I42 I42 J158 P236 K660 Q433 R230 Q249
B376 P375 I420 I424 J159 P236 K661 P548 R509 P819
B377 P375 I421 Q248 J16 P23 K720 P788 R568 P90
B378 P375 I422 I424 J18 P23 K729 P788 R571 P741
B379 P375 I429 I424 J180 P239 K732 P788 R58 P54
B509 P373 I442 Q246 J181 P239 K745 P788 R601 P833
B54 P37 I443 Q246 J188 P239 K746 P788 R628 P059
B582 P371 I455 Q246 J189 P239 K750 P788 R629 P059
B589 P371 I458 Q246 J386 Q318 K752 P788 R630 P929
D500 P549 I459 Q246 J439 P250 K758 P788 R638 P929
D609 D610 I460 P291 J69 P24 K759 P788 R75 B24
D62 P61 I469 P291 J690 P249
![Page 21: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/21.jpg)
World Health Organization Page 18
Annex Table D Country groupings used for regional tabulations
D.1 WHO Regions and Member States
WHO African Region
Algeria, Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African
Republic, Chad, Comoros, Congo, Côte d'Ivoire, Democratic Republic of the Congo, Equatorial Guinea,
Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Madagascar,
Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and
Principe, Senegal, Seychelles, Sierra Leone, South Africa, South Sudan, Swaziland, Togo, Uganda, United
Republic of Tanzania, Zambia, Zimbabwe
WHO Region of the Americas
Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Bolivia (Plurinational State of), Brazil,
Canada, Chile, Colombia, Costa Rica, Cuba, Dominica, Dominican Republic, Ecuador, El Salvador,
Grenada, Guatemala, Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru,
Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Suriname, Trinidad and Tobago,
United States of America, Uruguay, Venezuela (Bolivarian Republic of)
WHO South-East Asia Region
Bangladesh, Bhutan, Democratic People's Republic of Korea, India, Indonesia, Maldives, Myanmar,
Nepal, Sri Lanka, Thailand, Timor-Leste
WHO European Region
Albania, Andorra, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria,
Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece,
Hungary, Iceland, Ireland, Israel, Italy, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Luxembourg, Malta,
Monaco, Montenegro, Netherlands, Norway, Poland, Portugal, Republic of Moldova, Romania, Russian
Federation, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Tajikistan, The former
Yugoslav Republic of Macedonia, Turkey, Turkmenistan, Ukraine, United Kingdom, Uzbekistan
WHO Eastern Mediterranean Region
Afghanistan, Bahrain, Djibouti, Egypt, Iran (Islamic Republic of), Iraq, Jordan, Kuwait, Lebanon, Libya,
Morocco, Oman, Pakistan, Qatar, Saudi Arabia, Somalia, Sudan, Syrian Arab Republic, Tunisia, United
Arab Emirates, Yemen
WHO Western Pacific Region
Australia, Brunei Darussalam, Cambodia, China, Cook Islands, Fiji, Japan, Kiribati, Lao People's
Democratic Republic, Malaysia, Marshall Islands, Micronesia (Federated States of), Mongolia, Nauru,
New Zealand, Niue, Palau, Papua New Guinea, Philippines, Republic of Korea, Samoa, Singapore,
Solomon Islands, Tonga, Tuvalu, Vanuatu, Viet Nam
![Page 22: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/22.jpg)
World Health Organization Page 19
D.2 Countries grouped by WHO Region and average income per capita*
High income
Andorra, Australia, Austria, Bahamas, Bahrain, Barbados, Belgium, Brunei Darussalam Canada, Croatia,
Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany Greece, Hungary, Iceland, Ireland,
Israel, Italy, Japan, Kuwait, Luxembourg, Malta, Monaco, Netherlands, ,New Zealand, Norway, Oman, Poland,
Portugal, Qatar, Republic of Korea, Saint Kitts and Nevis, San Marino, Saudi Arabia, Singapore, Slovakia,
Slovenia, Spain, Sweden, Switzerland, Trinidad and Tobago, United Arab Emirates, United Kingdom, United
States of America
Low and middle income
WHO African Region
Algeria, Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic,
Chad, Comoros, Congo, Côte d'Ivoire, Democratic Republic of the Congo, Equatorial Guinea**, Eritrea,
Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali,
Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and Principe, Senegal,
Seychelles, Sierra Leone, South Africa, South Sudan, Swaziland, Togo, Uganda, United Republic of Tanzania,
Zambia, Zimbabwe
WHO Region of the Americas
Antigua and Barbuda, Argentina, Belize, Bolivia (Plurinational State of), Brazil, Chile, Colombia, Costa Rica,
Cuba, Dominica, Dominican Republic, Ecuador, El Salvador, Grenada Guatemala, Guyana, Haiti, Honduras,
Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Saint Lucia, Saint Vincent and the Grenadines,
Suriname, Uruguay, Venezuela (Bolivarian Republic of)
WHO South-East Asia Region
Bangladesh, Bhutan, Democratic People's Republic of Korea, India, Indonesia, Maldives, Myanmar, Nepal, Sri
Lanka, Thailand, Timor-Leste
WHO European Region
Albania, Armenia, Azerbaijan, Belarus, Bosnia and Herzegovina, Bulgaria, Georgia, Kazakhstan, Kyrgyzstan,
Latvia, Lithuania, Montenegro, Republic of Moldova, Romania, Russian Federation, Serbia, Tajikistan, The
former Yugoslav Republic of Macedonia, Turkey, Turkmenistan, Ukraine, Uzbekistan
WHO Eastern Mediterranean Region
Afghanistan, Djibouti, Egypt, Iran (Islamic Republic of), Iraq, Jordan, Lebanon, Libya, Morocco, Pakistan,
Somalia, Sudan, Syrian Arab Republic, Tunisia, Yemen
WHO Western Pacific Region
Cambodia, China, Cook Islands, Fiji, Kiribati, Lao People's Democratic Republic, Malaysia, Marshall Islands,
Micronesia (Federated States of), Mongolia, Nauru***, Niue***, Palau, Papua New Guinea, Philippines,
Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu, Viet Nam
* This regional grouping classifies WHO Member States according to the World Bank income and geographic regional categories
for the year 2011 (World Bank list of economies, July 2012)
** Equatorial Guinea is classified by the World Bank as high income, it is kept here with upper middle income to avoid a
regional grouping containing only one country and because its mortality profile is not dissimilar to neighbouring countries.
*** Nauru and Niue have been classified into income groups using gross domestic product.
![Page 23: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/23.jpg)
World Health Organization Page 20
D.3 World Bank income grouping*
Low income
Afghanistan, Bangladesh, Benin, Burkina Faso, Burundi, Cambodia, Central African Republic, Chad
Comoros, Democratic People's Republic of Korea, Democratic Republic of the Congo, Eritrea, Ethiopia
Gambia, Guinea, Guinea-Bissau, Haiti, Kenya, Kyrgyzstan, Liberia, Madagascar, Malawi, Mali, Mauritania,
Mozambique, Myanmar, Nepal, Niger Rwanda, Sierra Leone, Somalia, Tajikistan, Togo, Uganda, United
Republic of Tanzania, Zimbabwe
Lower middle income
Albania, Armenia, Belize, Bhutan, Bolivia (Plurinational State of), Cameroon, Cape Verde, Congo, Côte
d'Ivoire, Djibouti, Egypt, El Salvador, Fiji, Georgia, Ghana, Guatemala, Guyana, Honduras, India,
Indonesia, Iraq, Kiribati, Lao People's Democratic Republic, Lesotho, Marshall Islands, Micronesia
(Federated States of), Mongolia, Morocco, Nicaragua, Nigeria, Pakistan, Papua New Guinea, Paraguay,
Philippines, Republic of Moldova, Samoa, Sao Tome and Principe, Senegal, Solomon Islands, South
Sudan, Sri Lanka, Sudan, Swaziland, Syrian Arab Republic, Timor-Leste, Tonga, Ukraine, Uzbekistan,
Vanuatu, Viet Nam, Yemen Zambia
Upper middle income
Algeria, Angola, Antigua and Barbuda, Argentina, Azerbaijan, Belarus, Bosnia and Herzegovina,
Botswana, Brazil, Bulgaria, Chile, China, Colombia, Cook Islands, Costa Rica, Cuba, Dominica, Dominican
Republic, Ecuador, Equatorial Guinea**, Gabon, Grenada, Iran (Islamic Republic of), Jamaica, Jordan,
Kazakhstan, Latvia, Lebanon, Libya, Lithuania, Malaysia, Maldives, Mauritius, Mexico Montenegro,
Namibia, Nauru***, Niue***, Palau, Panama, Peru, Romania, Russian Federation, Saint Lucia, Saint
Vincent and the Grenadines, Serbia, Seychelles, South Africa, Suriname, Thailand, The former Yugoslav
Republic of Macedonia, Tunisia, Turkey, Turkmenistan, Tuvalu, Uruguay, Venezuela (Bolivarian Republic
of)
High income
Andorra, Australia, Austria, Bahamas, Bahrain, Barbados, Belgium, Brunei Darussalam Canada, Croatia,
Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany Greece, Hungary, Iceland, Ireland,
Israel, Italy, Japan, Kuwait, Luxembourg, Malta, Monaco, Netherlands, ,New Zealand, Norway, Oman,
Poland, Portugal, Qatar, Republic of Korea, Saint Kitts and Nevis, San Marino, Saudi Arabia, Singapore,
Slovakia, Slovenia, Spain, Sweden, Switzerland, Trinidad and Tobago, United Arab Emirates, United
Kingdom, United States of America
* This regional grouping classifies WHO Member States according to the World Bank income categories for the year 2011
(World Bank list of economies, July 2012)
** Equatorial Guinea is classified by the World Bank as high income, it is kept here with upper middle income to avoid a
regional grouping containing only one country and because its mortality profile is not dissimilar to neighbouring countries.
*** Nauru and Niue have been classified into income groups using gross domestic product.
![Page 24: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/24.jpg)
World Health Organization Page 21
D.4 World Bank Regions
High income
Andorra, Australia, Austria, Bahamas, Bahrain, Barbados, Belgium, Brunei Darussalam Canada, Croatia,
Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany Greece, Hungary, Iceland, Ireland,
Israel, Italy, Japan, Kuwait, Luxembourg, Malta, Monaco, Netherlands, ,New Zealand, Norway, Oman,
Poland, Portugal, Qatar, Republic of Korea, Saint Kitts and Nevis, San Marino, Saudi Arabia, Singapore,
Slovakia, Slovenia, Spain, Sweden, Switzerland, Trinidad and Tobago, United Arab Emirates, United
Kingdom, United States of America
East Asia and Pacific
Cambodia, China, Cook Islands, Democratic People's Republic of Korea, Fiji, Indonesia, Kiribati, Lao
People's Democratic Republic, Malaysia, Marshall Islands, Micronesia (Federated States of), Mongolia,
Myanmar, Nauru, Niue, Palau, Papua New Guinea, Philippines, Samoa, Solomon Islands, Thailand,
Timor-Leste, Tonga, Tuvalu, Vanuatu, Viet Nam
Europe and Central Asia
Albania, Armenia, Azerbaijan, Belarus, Bosnia and Herzegovina, Bulgaria, Georgia, Kazakhstan,
Kyrgyzstan, Latvia, Lithuania, Montenegro Republic of Moldova, Romania, Russian Federation, Serbia,
Tajikistan, The former Yugoslav Republic of Macedonia, Turkey, Turkmenistan, Ukraine, Uzbekistan
Latin America and Caribbean
Antigua and Barbuda, Argentina, Belize, Bolivia (Plurinational State of), Brazil, Chile, Colombia, Costa
Rica, Cuba, Dominica, Dominican Republic, Ecuador, El Salvador, Grenada, Guatemala, Guyana, Haiti,
Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Saint Lucia, Saint Vincent and the
Grenadines, Suriname, Uruguay, Venezuela (Bolivarian Republic of)
Middle East and North Africa
Algeria, Djibouti, Egypt, Iran (Islamic Republic of), Iraq, Jordan, Lebanon ,Libya, Morocco, Syrian Arab
Republic, Tunisia, Yemen
South Asia
Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka
Sub-Saharan Africa
Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad,
Comoros, Congo, Côte d'Ivoire, Democratic Republic of the Congo, Equatorial Guinea**, Eritrea,
Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi,
Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and Principe,
Senegal, Seychelles, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Swaziland, Togo, Uganda,
United Republic of Tanzania, Zambia, Zimbabwe
** Equatorial Guinea is classified by the World Bank as high income, it is kept here with upper middle income to avoid a
regional grouping containing only one country and because its mortality profile is not dissimilar to neighbouring countries.
![Page 25: WHO-H il 2000-2011 · i A k wl g This Technical Paper was written by Colin Mathers and Li Liu with inputs and assistance from Wahyu Retno Mahanani, Jessica Ho and Doris Ma Fat. Estimates](https://reader035.vdocuments.mx/reader035/viewer/2022071000/5fbcacc898a0c4022d600c73/html5/thumbnails/25.jpg)
World Health Organization Page 22
D.5 Millennium Development Goal (MDG) Regions
Developed regions
Albania, Andorra, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada,
Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland,
Ireland, Israel, Italy, Japan, Latvia, Lithuania, Luxembourg, Malta, Monaco, Montenegro, Netherlands,
New Zealand, Norway, Poland, Portugal, Republic of Moldova, Romania, Russian Federation, San
Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, The former Yugoslav Republic of
Macedonia, Ukraine, United Kingdom, United States of America
Developing regions
Caucasus and Central Asia
Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan
Eastern Asia China, Democratic People's Republic of Korea, Mongolia, Republic of Korea
Latin America and the Caribbean
Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Bolivia (Plurinational State of), Brazil, Chile,
Colombia, Costa Rica, Cuba, Dominica, Dominican Republic, Ecuador, El Salvador, Grenada, Guatemala,
Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Saint Kitts and Nevis,
Saint Lucia, Saint Vincent and the Grenadines, Suriname, Trinidad and Tobago, Uruguay, Venezuela
(Bolivarian Republic of)
Northern Africa Algeria, Egypt, Libya, Morocco, Tunisia
Oceania
Cook Islands, Fiji, Kiribati, Marshall Islands, Micronesia (Federated States of), Nauru, Niue, Palau, Papua
New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu
South-eastern Asia
Brunei Darussalam, Cambodia, Indonesia, Lao People's Democratic Republic, Malaysia, Myanmar,
Philippines, Singapore, Thailand, Timor-Leste, Viet Nam
Southern Asia
Afghanistan, Bangladesh, Bhutan, India, Iran (Islamic Republic of), Maldives, Nepal, Pakistan, Sri Lanka
Sub-Saharan Africa
Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad,
Comoros, Congo, Côte d'Ivoire, Democratic Republic of the Congo, Djibouti, Equatorial Guinea, Eritrea,
Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi,
Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and Principe,
Senegal, Seychelles, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Swaziland, Togo, Uganda,
United Republic of Tanzania, Zambia, Zimbabwe
Western Asia Bahrain, Iraq, Jordan, Kuwait, Lebanon, Oman, Qatar Saudi Arabia, Syrian Arab
Republic, Turkey, United Arab Emirates, Yemen